-
Ohio’s Attorney General fears the state might not be able to get the $808 million it had hoped from the proposed $26 billion national settlement with…
-
Payouts will be spread over the next 18 years, with much of the funding going to help communities struggling with high rates of opioid addiction and overdose deaths.
-
Four of the biggest American health companies have tentatively agreed to pay $26 billion to settle their opioid liability. Tax breaks could allow them to claw back $4 billion.
-
McKinsey is the latest major American corporation to face legal, financial and public relations peril stemming from its role in the nation's deadly opioid epidemic.
-
The giant retailer shipped billions of opioid pills to pharmacies nationwide. An NPR investigation found employees warned company executives their stores were being used by "pill mill" doctors.
-
The corporate consulting giant issued a rare apology for its behind-the-scenes work with Purdue Pharma, maker of OxyContin. One senator called McKinsey's behavior "abhorrent."
-
The controversial deal hashed out between the Department of Justice and the maker of Oxycontin provides hundreds of millions of dollars of relief for communities hit hard by the opioid epidemic.
-
President Trump promised to end America's opioid crisis. On his watch overdose deaths flattened in 2018 then surged again to record levels.
-
Thousands of lawsuits that ground to a halt because of COVID-19 are moving forward again as local, state and federal courts reopen around the U.S.
-
A federal judge overseeing opioid litigation in Cleveland has ruled against a request by five pharmacy chains to dismiss lawsuits filed by Lake and…